Table 3. Clinical response of advanced colorectal adenocarcinoma patients to gemcitabine, oxaliplatin, and infusional levo-folinic acid and 5-fluorouracil (GOLF) multidrug chemotherapy.

Number	PD	CR	PR	SD	NE
289	6	3	9	10	1
100%	20.7%	10.3%	31.2%	34.4%	3.4%

PD=progressive disease; CR=complete response; PR=partial response; SD=stable disease; NE=nonevaluable for response for early death. The time to progression was 7.26 months (95% of CI 6.88–12.62). The overall survival was 22 months (95% CI 12.6–26.5).